Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

ARSENICAL DERMATITIS PRODUCED IN TREATMENT OF TRICHOMONAS VAGINITIS: REPORT OF FIVE CASES

ARSENICAL DERMATITIS PRODUCED IN TREATMENT OF TRICHOMONAS VAGINITIS: REPORT OF FIVE CASES This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Acetarsone and related compounds containing pentavalent arsenic are used with increasing frequency in the treatment of infections caused by Trichomonas vaginalis. It seemed of interest to report briefly four cases in which localized dermatitis followed the use of one of these compounds and in which the course, the appearance and the distribution of the eruption were strikingly similar. In a fifth case to be reported the dermatitis produced was generalized and indistinguishable from that produced by the arsphenamines. REPORT OF CASES Cases 1, 2 and 3.— Three women with resistant trichomonas vaginitis received weekly or bimonthly treatments over periods of eight, ten and fourteen months, respectively. None gave a history of previous dermatitis or of treatment with arsenic. All received the insufflation treatment for infection due to Trichomonas with a preparation labeled "powdex—formula 21." The composition stated on the label wasNo cutaneous symptoms were noted by any of these http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology and Syphilology American Medical Association

ARSENICAL DERMATITIS PRODUCED IN TREATMENT OF TRICHOMONAS VAGINITIS: REPORT OF FIVE CASES

Loading next page...
 
/lp/american-medical-association/arsenical-dermatitis-produced-in-treatment-of-trichomonas-vaginitis-qtYOyvG8Sk

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1938 American Medical Association. All Rights Reserved.
ISSN
0096-6029
DOI
10.1001/archderm.1938.01480140038003
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Acetarsone and related compounds containing pentavalent arsenic are used with increasing frequency in the treatment of infections caused by Trichomonas vaginalis. It seemed of interest to report briefly four cases in which localized dermatitis followed the use of one of these compounds and in which the course, the appearance and the distribution of the eruption were strikingly similar. In a fifth case to be reported the dermatitis produced was generalized and indistinguishable from that produced by the arsphenamines. REPORT OF CASES Cases 1, 2 and 3.— Three women with resistant trichomonas vaginitis received weekly or bimonthly treatments over periods of eight, ten and fourteen months, respectively. None gave a history of previous dermatitis or of treatment with arsenic. All received the insufflation treatment for infection due to Trichomonas with a preparation labeled "powdex—formula 21." The composition stated on the label wasNo cutaneous symptoms were noted by any of these

Journal

Archives of Dermatology and SyphilologyAmerican Medical Association

Published: Aug 1, 1938

There are no references for this article.